Alliancebernstein L.P. Unity Biotechnology, Inc. Transaction History

Alliancebernstein L.P.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 30, 2021	SELL	$4.15 - $6.3 $218,634 - $331,902	-52,683 Closed	0 $0
Q1 2021 May 06, 2021	BUY	$5.51 - $9.42 $97,433 - $166,573	17,683 Added 50.52%	52,683 $316,000
Q3 2020 Nov 12, 2020	SELL	$2.94 - $12.43 $65,097 - $275,225	-22,142 Reduced 38.75%	35,000 $121,000
Q2 2020 Aug 13, 2020	BUY	$5.28 - $9.67 $47,520 - $87,030	9,000 Added 18.69%	57,142 $496,000
Q1 2020 May 14, 2020	BUY	$5.0 - $7.6 $34,000 - $51,680	6,800 Added 16.45%	48,142 $279,000
Q3 2019 Nov 14, 2019	BUY	$5.62 - $9.63 $38,216 - $65,484	6,800 Added 19.69%	41,342 $252,000
Q2 2019 Aug 14, 2019	BUY	$7.59 - $10.21 $48,576 - $65,344	6,400 Added 22.74%	34,542 $328,000
Q1 2019 May 14, 2019	BUY	$7.65 - $16.66 $109,395 - $238,238	14,300 Added 103.31%	28,142 $228,000
Q4 2018 Feb 13, 2019	BUY	$10.76 - $17.25 $148,939 - $238,774	13,842 New	13,842 $225,000

4.41M

Ticker UBX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 14,036,200
Market Cap $14M
Description
Unity Biotechnology, Inc., a biotechnology company, engages in the research and development of therapeutics to slow, halt, or reverse diseases of aging. The company's lead drug candidate includes UBX1325, which is Phase II clinical trial for the treatment of age-related diseases of the eye, including diabetic macular edema, age-related macular d...

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

Stay updated on Alliancebernstein L.P. with notifications on news.